Human Hepatitis C Virus (HCV) Peripheral Blood Mononuclear Cells

Description

Human Hepatitis C Virus (HCV) Peripheral Blood Mononuclear Cells (PBMCs) are mainly derived from the peripheral blood of HCV-infected patients. HCV invades cells by binding to receptors such as CD81 and SR-BI on the surface of PBMCs through the envelope glycoprotein E1/E2, replicates at a low level in the cytoplasm, and forms a persistent infection reservoir. These PBMCs, comprising lymphocytes and monocytes, exhibit a characteristic non-adherent, suspension growth pattern. HCV can replicate within PBMCs, evading immune surveillance and perpetuating chronic inflammation. Persistent infection establishes viral reservoirs, contributing to systemic complications such as cirrhosis, hepatocellular carcinoma, and neurocognitive dysfunction. These effects may arise from both direct viral invasion of the central nervous system and PBMC-mediated chronic immune activation. These PBMCs facilitate evaluation of autoimmune markers in hepatitis C, support monitoring of Hep C disease progression, are prepared via standardized PBMC isolation hepatitis C, enable studies of immune modulation in HCV and immune response in hepatitis C, aid development of novel therapies involving PBMC HCV.